Financial News
Atea Pharmaceuticals, Inc. - common stock (NQ:AVIR)
4.510
-0.310
(-6.43%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 28, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 1,392,407 |
| Open | 4.830 |
| Bid (Size) | 3.500 (200) |
| Ask (Size) | 4.510 (100) |
| Prev. Close | 4.820 |
| Today's Range | 3.820 - 4.920 |
| 52wk Range | 2.780 - 6.450 |
| Shares Outstanding | 83,399,377 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Earnings Scheduled For November 12, 2025 ↗
November 12, 2025
Atea Pharmaceuticals Q1 Earnings Call Highlights ↗
May 12, 2026
Atea Pharma (AVIR) Earnings Call Transcript ↗
March 05, 2026
Atea Pharma (AVIR) Earnings Call Transcript ↗
November 13, 2025
Frequently Asked Questions
Is Atea Pharmaceuticals, Inc. - common stock publicly traded?
Yes, Atea Pharmaceuticals, Inc. - common stock is publicly traded.
What exchange does Atea Pharmaceuticals, Inc. - common stock trade on?
Atea Pharmaceuticals, Inc. - common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Atea Pharmaceuticals, Inc. - common stock?
The ticker symbol for Atea Pharmaceuticals, Inc. - common stock is AVIR on the Nasdaq Stock Market
What is the current price of Atea Pharmaceuticals, Inc. - common stock?
The current price of Atea Pharmaceuticals, Inc. - common stock is 4.510
When was Atea Pharmaceuticals, Inc. - common stock last traded?
The last trade of Atea Pharmaceuticals, Inc. - common stock was at 07/28/26 04:00 PM ET
What is the market capitalization of Atea Pharmaceuticals, Inc. - common stock?
The market capitalization of Atea Pharmaceuticals, Inc. - common stock is 376.13M
How many shares of Atea Pharmaceuticals, Inc. - common stock are outstanding?
Atea Pharmaceuticals, Inc. - common stock has 376M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
